drugset / Trial / NCT00450138
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vandetanib | Small molecule | — | Oral |
| Background | Cisplatin | Other / unclassified | — | Intravenous |